EBITDA (Annual)

EBITDA: Income before interest, taxes, depreciation and amortization.

MiMedx Group, Inc (MDXG) had EBITDA of $78.77M for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$418.63M
Net Income	$48.58M
Cost of Goods Sold	$73.01M
Gross Profit	$345.62M
Operating Expenses	$354.74M
Operating Income	$63.89M
Non-Operating Income/Expense	$2.38M
Pre-Tax Income	$66.26M
Normalized Pre-Tax Income	$66.26M
Income after Taxes	$48.58M
Income from Continuous Operations	$48.58M
Consolidated Net Income/Loss	$48.58M
Normalized Income after Taxes	$48.58M
EBIT	$63.89M
EBITDA	$78.77M
Weighted-Average Shares Outstanding (Basic)	147.79M
Weighted-Average Shares Outstanding (Diluted)	149.72M
Earnings per Share (EPS) (Basic)	$0.33
Earnings per Share (EPS) (Diluted)	$0.32
Balance Sheet Financials
Current Assets	$277.47M
Property, Plant, and Equipment	$4.71M
Long-Term Assets	$65.18M
Total Assets	$342.65M
Current Liabilities	$64.27M
Long-Term Debt	$16.47M
Long-Term Liabilities	$21.84M
Total Liabilities	$86.11M
Common Equity	$256.55M
Tangible Shareholders Equity	$222.95M
Shareholders Equity	$256.55M
Common Shares Outstanding	148.09M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$74.00M
Cash Flow from Investing Activities	$-6.89M
Cash Flow from Financial Activities	$-5.41M
Beginning Cash	$104.42M
End Cash	$166.12M
Increase/Decrease in Cash	$61.70M
Stock-Based Compensation	$16.40M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	4.32
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.06
Debt to Equity Ratio	0.07
Gross Margin	82.56%
Operating Margin	15.26%
EBIT Margin	15.26%
EBITDA Margin	18.82%
Pre-Tax Profit Margin	15.83%
Profit Margin	11.60%
Free Cash Flow	$72.97M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.22
Inventory Turnover	2.88
Receiveable Turnover	5.53
Days Sales in Receivables	66.01
Return on Equity	18.94%
Return on Tangible Equity	21.79%
Return on Assets	14.18%
Return on Investments	17.79%
Book Value Per Share	$1.73
Free Cash Flow per Share	$0.49
Operating Cash Flow per Share	$0.49

Data from Zacks Investment Research, Inc.